| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Bitterroot Valley Living Ctr is a Stevensville, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Protech Home Medical is a rapidly growing leader in the provision of clinical respiratory equipment and service to patients.
Infusion Associates is a physician practice that specializes in IV infusions and injections. They provide medically prescribed infusions for patients with chronic disease in a comfortable, outpatient environment instead of a hospital.
Integrity Training Solutions is a Canal Winchester, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.